Sunder Mudaliar

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Frank L. Greenway, Ken Fujioka, Raymond A Plodkowski et al. · The Lancet · 2010 · 1K citations

Medicine, Pharmacology, Pharmacotherapy +11

Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

Sunder Mudaliar, Robert R. Henry, Arun J. Sanyal et al. · Gastroenterology · 2013 · 915 citations

Medicine, Endocrinology, Pharmacology +12

Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance

Ralph A. DeFronzo, Devjit Tripathy, Dawn C. Schwenke et al. · New England Journal of Medicine · 2011 · 743 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Acute and Chronic Effect of Insulin on Leptin Production in Humans: Studies In Vivo and In Vitro

Jerzy W. Kolaczynski, Mark R. Nyce, Robert V. Considine et al. · Diabetes · 1996 · 710 citations · Full text

Medicine, Biochemistry, Endocrinology +11